<DOC>
	<DOCNO>NCT02981225</DOCNO>
	<brief_summary>The purpose study describe , 6 week , evolution depressive symptom patient mild moderate major depression strategy Phytostandard® Rhodiola-Saffron supplementation</brief_summary>
	<brief_title>Descriptive Study Management Strategy Mild Moderate Major Depression : Combination Rhodiola Saffron Extracts .</brief_title>
	<detailed_description>For study , 52 patient go include . They supplementation Phytostandard® rhodiola/saffron , 2 tablet per day 42 day . one hand , two visit ( inclusion follow-up ) , investigator completes Hamilton Depression Scale ( HAM-D ) Clinical Global Impression ( CGI ) . During inclusion visit , complete patient CIM-10 depression diagnostic . hand , patient complete HAD 4 time : inclusion visit , day 14 , day 28 follow-up visit . He complete Patient Global Impression time .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>Suffering mild moderate depression define CIM10 Having score HAMD questionnaire 8 18 Having agree participate study inform investigator Depressive patient already medication discontinuation medication less month ago Patients severe depression define CIM10 HAMD &gt; 18 Patients consider risk : attempt suicide suicidal ( observed investigator Hamilton item 3 score &gt; 2 ) Patients psychiatric disorder : schizophrenia , bipolarity , addiction ( drug , alcohol ... ) , etc . Patient severe disease ( cancer , kidney heart disease ) patient contraindication take product ( patient antihypertensive ... ) Patients use agent contain piperine St. John 's wort ( interaction ) Pregnant breastfeed patient Patients wish complement Phytostandard® Rhodiola Saffron . Patients wish participate study . Patients unable understand in out study ( mental incapacity , language barrier ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>